ARCHIVES

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Approvals: Cobas HPV Test Approved For Primary Cervical Screening

April 25, 2014

BMS Settles Charges Of Obstructing Generics

March 14, 2003

NCI Director Among Bush Appointees Asked To Submit Resignation.

December 12, 2008

Geography Still An Issue For Centers: Durant Asks Is It “Holy Water” or Money

April 26, 1985

Broder On FDA: Don’t Blame Them For Doing Their Jobs (They Have To Work At Parklawn)

September 27, 1991

ASCO Urges Increase In Research Funding, Removal of Barriers For Trial Participation

January 23, 2009